BUSINESS
Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri
Biocon and Mylan N.V. have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri,…